FSDIX
Price
$17.79
Change
+$0.08 (+0.45%)
Updated
Jul 3 closing price
Net Assets
5.21B
JAVAX
Price
$15.00
Change
+$0.09 (+0.60%)
Updated
Jul 3 closing price
Net Assets
26.1M
Interact to see
Advertisement

FSDIX vs JAVAX

Header iconFSDIX vs JAVAX Comparison
Open Charts FSDIX vs JAVAXBanner chart's image
Fidelity Strategic Dividend & Income
Price$17.79
Change+$0.08 (+0.45%)
VolumeN/A
Net Assets5.21B
James Aggressive Allocation
Price$15.00
Change+$0.09 (+0.60%)
VolumeN/A
Net Assets26.1M
FSDIX vs JAVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSDIX vs. JAVAX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSDIX is a Buy and JAVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSDIX has more cash in the bank: 5.21B vs. JAVAX (26.1M). FSDIX pays higher dividends than JAVAX: FSDIX (2.44) vs JAVAX (0.64). FSDIX was incepted earlier than JAVAX: FSDIX (22 years) vs JAVAX (10 years). JAVAX (1.02) is less costly to investors than FSDIX (0.63). FSDIX is a more actively managed with annual turnover of: 36.00 vs. JAVAX (19.00). FSDIX has a lower initial minimum investment than JAVAX: FSDIX (0) vs JAVAX (10000). JAVAX annual gain was more profitable for investors over the last year : 10.60 vs. FSDIX (8.86). JAVAX return over 5 years is better than : 66.37 vs. FSDIX (38.08).
FSDIXJAVAXFSDIX / JAVAX
Total Expense Ratio0.631.0262%
Annual Report Gross Expense Ratio0.631.0262%
Fund Existence22 years10 years-
Gain YTD5.7555.520104%
Front LoadN/AN/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.21B26.1M19,954%
Annual Yield % from dividends2.440.64382%
Returns for 1 year8.8610.6084%
Returns for 3 years22.2054.6041%
Returns for 5 years38.0866.3757%
Returns for 10 years48.9260.9180%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FHCIX60.48N/A
N/A
Fidelity Advisor Health Care I
DRIPX29.09N/A
N/A
The MP 63
PRUFX111.15N/A
N/A
T. Rowe Price Growth Stock I
FCEUX18.06N/A
N/A
Franklin U.S. Core Equity Advisor
VSGEX7.72N/A
N/A
Virtus SGA International Growth C